Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer()

AIM: Improving survival for women with early breast cancer (eBC) requires greater attention to the consequences of treatment, including risk to ovarian function. We have assessed whether biochemical markers of the ovarian reserve might improve prediction of chemotherapy related amenorrhoea. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Richard A., Rosendahl, Mikkel, Kelsey, Thomas W., Cameron, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807650/
https://www.ncbi.nlm.nih.gov/pubmed/23968732
http://dx.doi.org/10.1016/j.ejca.2013.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807650/
https://www.ncbi.nlm.nih.gov/pubmed/23968732
http://dx.doi.org/10.1016/j.ejca.2013.07.014

Ejemplares similares